Well-established as a major journal in today's rapidly advancing experimental and clinical research, Endocrine publishes full-length original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical (including proof of concept studies and clinical trials) research in all the different fields of endocrinology and metabolism. Endocrine covers the following leading topics in Endocrinology such as: Neuroendocrinology, Pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, type 1 and type 2 diabetes, hormones of male and female reproduction, and of HPA axis, pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
- Covers leading topics in endocrinology
- Includes Hormones of reproduction, metabolism, growth, and ion balance
- Offers the latest on insulin and diabetes
- Presents newly-emerging endocrine-related topics
- 94% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
Journal information
- Editor-in-Chief
-
- Sebastiano Filetti
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
Journal metrics
- 3.235 (2019)
- Impact factor
- 3.019 (2019)
- Five year impact factor
- 25 days
- Submission to first decision
- 84 days
- Submission to acceptance
- 347,225 (2019)
- Downloads
Latest issue
Latest articles
Journal updates
-
COVID-19 and impact on peer review
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
-
Call for papers focusing on the COVID-19 outbreak and endocrine-diabetes-metabolic disease
The pandemic COVID-19 is significantly affecting the general population and vulnerable people with endocrine, diabetic, and metabolic disease. We encourage COVID-19-related research submissions regarding research on the relationship between COVID-19 and endocrine disorders as well as on the experience of diabetic and endocrine patients subject to lockdown and social distancing guidelines. We will expedite the publication of accepted manuscripts on these topics, which Springer Nature is making free-to-access for the duration of the WHO Public Health Emergency of International Concern.
-
About this journal
- Electronic ISSN
- 1559-0100
- Abstracted and indexed in
-
- AGRICOLA
- BIOSIS
- Biological Abstracts
- CAB Abstracts
- CNKI
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- Dimensions
- EBSCO Biomedical Reference Collection
- EBSCO Discovery Service
- EMBASE
- Elsevier Biobase
- Google Scholar
- Highbeam
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Pathway Studio
- ProQuest Biological Science Database
- ProQuest Central
- ProQuest Natural Science Collection
- ProQuest SciTech Premium Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Qinsight
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index
- Science Citation Index Expanded (SciSearch)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Copyright information
-
© Springer Science+Business Media, LLC, part of Springer Nature
